Supporting people in hospitals across South Australia through vital health and medical research and improved patient care.
Meet our passionate and dedicated team.
Meet our Board and Governance team.
THRF adopts extremely high transparency standards when reporting our financials.
Supports research into the detection, management & treatment of breast cancer.
Funding research into prostate cancer prevention, detection & treatment.
Improving heart health through advances in knowledge & research to beat heart disease.
Our aim is to reduce & eliminate the high incidence of chronic kidney disease and diabetes.
Supports health and wellbeing research & programs for veterans, emergency service personnel and their families.
Driving collaboration, innovation & research to develop best-practice arts, design & health programs.
Supporting world-class stroke research to improve prevention, diagnosis & acute treatment to cure stroke.
Providing donor stool to treat patients with bowel conditions and foster research into faecal transplant as a treatment.
Do you want to join our team? Check out current career opportunities here.
View some of the commonly asked questions about our organisation.
We are so grateful to those who donate their time and skills to support life-changing medical research. Find out more…
Get in touch with us here.
Thanks to your generous support, each year The Hospital Research Foundation (THRF) funds travel grants to support researchers and students to attend various conferences and meetings relevant to their field of research, having the opportunity to network with fellow researchers around the globe.
PhD student Alexandra (Alex) Shoubridge from the Breast Cancer Research Unit at the Basil Hetzel Institute for Translational Health Research recently attended the American Society for Bone and Mineral Research 2017 Annual Meeting (ASBMR). The meeting was held in Colorado, USA in September. Below is Alex’s personal reflection of her trip which includes exciting insights and opportunities from attending.
The ASBMR annual meeting is one of few international gatherings for orthopaedic surgeons and researchers. The meeting this year had a strong focus on cell degeneration and how this could affect poor bone health in the elderly.
This meeting was a fantastic opportunity to hear from current major clinical trials and results of these studies, particularly the recently completed study looking at fracture risk in post-menopausal women. Although this was not directly in my area of work, these meetings are an important opportunity to be updated on the progress which is being made in all aspects of orthopaedic research.
I was given the opportunity to present a poster which highlighted my findings from my PhD and I was able to discuss my thought process through my PhD and the approaches I took as well as my aims.
Making sure I made the most of my trip I had the opportunity to catch up with orthopaedic lab heads from Adelaide, including Professor Gerald Atkins, Associate Professor Paul Anderson and Professor David Findlay where we discussed potential post-doctoral positions after the completion of my PhD, which is expected to be finished in 2018.
The opportunities didn’t stop there and I was also able to briefly reconnect with international researchers I had met at previous conferences in both South Australia and Queensland which is important if I choose to remain in the field of orthopaedics.
In addition to attending the conference, I was fortunate to visit the Centre for Life Sciences, based within the Harvard Medical School. This was a fantastic opportunity to catch up with Dr Kahn whom I met at the 2016 Australian and New Zealand Bone and Mineral Society in Queensland where she granted me the opportunity to meet her in the USA and discuss potential projects.
Personally, it was a fantastic opportunity to observe how a lab runs so efficiently which differs from labs based in Adelaide. I was also invited to give an oral presentation to Dr Kahn and her lab discussing our labs recent studies and my PhD project.
It was a pleasure to receive such interest in my work from the lab and I also received some interesting comments as some of the researchers had previously worked in the field of orthopaedics.
Overall, I found this trip a fantastic opportunity to broaden my knowledge in the field of orthopaedics and to see how other international research organisations conduct research.
I have greatly appreciated the funding support by THRF and their donors for allowing me the opportunity to travel overseas and gain these experiences. I am so grateful to be given several career opportunities available to be as a result of this trip.
Please donate today and give our researchers and students the opportunities to learn the insights in their fields.
Whilst estrogen receptor positive breast cancer has a targeted treatment strategy, many patients develop resistance, leaving them with no option other than chemotherapy. Now these women have hope! read more
Did you know, every day in Australia approximately 50 people are diagnosed with breast cancer? read more
It was a pain in her right breast, like that of a torn muscle, which led young mother Kate Shields to a breast cancer diagnosis that she never saw coming. In January last year the 38-year-old mother was diagnosed with aggressive hormonal breast cancer. read more
Always fit and healthy, 56-year-old Deb Holsman never thought she would be diagnosed with breast cancer, let alone one of the most heartbreaking forms of the disease. read more
The Breast Cancer Research Unit at the Basil Hetzel Institute for Translational Health Research (BHI) are determined to develop a new immunotherapy treatment to target breast cancer and other heartbreaking cancers affecting our community. read more
Head of the Cell Signalling Laboratory at the Centre for Cancer Biology (CCB), Associate Professor Yeesim Khew-Goodall is leading a crucial research project focused on overcoming resistance to cancer therapy, particularly in triple negative breast cancer. read more
Can you imagine being diagnosed with a type of cancer that has no targeted treatments? This could change thanks to researchers at the Basil Hetzel Institute for Translational Health Research (BHI) who are working hard to investigate possible treatments for triple negative breast cancer. read more
World-first research is underway at the Basil Hetzel Institute for Translational Health Research (BHI) focusing on using our own immune system to fight solid cancers such as breast cancer with potential for other cancers. read more
Thanks to the incredible generosity of one of our very special donors, Dr Margaret Elcombe, our researchers have been awarded the Elcombe Pre-Clinical Project Grant to pursue a promising new treatment avenue for breast cancer that has spread which if successful would be far less toxic than current treatments. read more